Abstract:β-Lactams are the most widely prescribed class of antibiotics that inhibit penicillin-binding proteins (PBPs), particularly transpeptidases that function in peptidoglycan synthesis. A major mechanism of antibiotic resistance is the production of β-lactamase enzymes, which are capable of hydrolyzing β-lactam antibiotics. There have been many efforts to counter increasing bacterial resistance against β-lactams. These studies have mainly focused on three areas: discovering novel inhibitors against β-lactamases, developing new β-lactams less susceptible to existing resistance mechanisms, and identifying non-β-lactam inhibitors against cell wall transpeptidases. Drug discovery in the β-lactam field has afforded a range of research opportunities for academia. In this review, we summarize the recent new findings on both β-lactamases and cell wall transpeptidases because these two groups of enzymes are evolutionarily and functionally connected. Many efforts to develop new β-lactams have aimed to inhibit both transpeptidases and β-lactamases, while several promising novel β-lactamase inhibitors have shown the potential to be further developed into transpeptidase inhibitors. In addition, the drug discovery progress against each group of enzymes is presented in three aspects: understanding the targets, screening methodology, and new inhibitor chemotypes. This is to offer insights into not only the advancement in this field but also the challenges, opportunities, and resources for future research. In particular, cyclic boronate compounds are now capable of inhibiting all classes of β-lactamases, while the diazabicyclooctane (DBO) series of small molecules has led to not only new β-lactamase inhibitors but potentially a new class of antibiotics by directly targeting PBPs. With the cautiously optimistic successes of a number of new β-lactamase inhibitor chemotypes and many questions remaining to be answered about the structure and function of cell wall transpeptidases, non-β-lactam transpeptidase inhibitors may usher in the next exciting phase of drug discovery in this field.

Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme

Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases

Molecular evolution of carbapenemases KPC-12 and molecular docking analysis of β-lactams

β-lactam antibiotic binding sites in Streptococcus pneumoniae StkP kinase extracellular region

Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies

Structural and computational analysis of peptide recognition mechanism of class-C type penicillin binding protein, alkaline D-peptidase from Bacillus cereus DF4-B

Antibiotic Binding To Monozinc Cpha Beta-Lactamase From Aeromonas Hydropila: Quantum Mechanical/Molecular Mechanical And Density Functional Theory Studies

Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99

Structural Basis for the Catalytic Activity of Filamentous Human Serine Beta-Lactamase-like Protein LACTB.

Structural basis for antibiotic transport and inhibition in PepT2

Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference

Crystal structure of vancomycin bound to the resistance determinant d-alanine-d-serine

Antibiotic Binding to Monozinc CphA Β-Lactamase from Aeromonas Hydropila: Quantum Mechanical/Molecular Mechanical and Density Functional Theory Studies

Conformational Studies Of Resin-Bound Vancomycin And The Complex Of Vancomycin And Ac-2-L-Lys-D-Ala-D-Ala

Time-resolved crystallography of boric acid binding to the active site serine of the β-lactamase CTX-M-14 and subsequent 1,2-diol esterification

Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam

Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis

Drug Discovery in the Field of β-Lactams: An Academic Perspective

Exploring the Structurally Conserved Regions and Functional Significance in Bacterial N-Terminal Nucleophile (Ntn) Amide-Hydrolases

Specificity of L,D-transpeptidases from gram-positive bacteria producing different peptidoglycan chemotypes

Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s)